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RESEARCH ARTICLE
MICROBIAL ECOLOGY
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Most studies of the human microbiome have focused on westernized people with life-style practices that decrease
microbial survival and transmission, or on traditional societies that are currently in transition to westernization. We
characterize the fecal, oral, and skin bacterial microbiome and resistome of members of an isolated Yanomami
Amerindian village with no documented previous contact with Western people. These Yanomami harbor a microbiome with the highest diversity of bacteria and genetic functions ever reported in a human group. Despite their
isolation, presumably for >11,000 years since their ancestors arrived in South America, and no known exposure to
antibiotics, they harbor bacteria that carry functional antibiotic resistance (AR) genes, including those that confer
resistance to synthetic antibiotics and are syntenic with mobilization elements. These results suggest that westernization significantly affects human microbiome diversity and that functional AR genes appear to be a feature of the
human microbiome even in the absence of exposure to commercial antibiotics. AR genes are likely poised for mobilization and enrichment upon exposure to pharmacological levels of antibiotics. Our findings emphasize the need
for extensive characterization of the function of the microbiome and resistome in remote nonwesternized populations before globalization of modern practices affects potentially beneficial bacteria harbored in the human body.

INTRODUCTION
Host-microbial interactions are important determinants of host physiology, including immune responses, metabolic homeostasis, and behavior (1–4). Microbiota transplantation can transfer phenotypes such
as nutritional status from donor to recipient (5, 6), indicating that altered microbial communities can therefore cause, as well as result from,
altered physiological states. Despite increasing evidence that the microbiome has important roles in human health, we do not yet know the
extent to which the human microbiome has changed during the adoption of life-styles associated with westernization. Here, we described the
microbiome from Yanomami subjects in the Amazon with no previous
report of contact with non-Yanomami. The Yanomami were originally
mountain people who were first contacted in the mid-1960s, and who
continue to live seminomadic hunter-gatherer life-styles in the Amazon
1
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jungle. In Venezuela, they inhabit a region protected from development,
and many still inhabit uncharted villages in the vast mountainous
Yanomami territory (7). These remote populations of hunter-gatherers
have life-styles similar to those of our human ancestors, and are unexposed to modern practices known to exert antimicrobial effects.
For instance, pharmacologic-dose antibiotic exposure is nearly ubiquitous worldwide, and all human microbiota studied to date, remote or
industrialized, harbor diverse antibiotic resistance (AR) genes (8, 9). Although AR genes have been computationally predicted in ancient oral
microbiota (10), functional resistance from the preantibiotic era remains largely uncharacterized. These subjects from an uncontacted
community therefore represent a unique proxy for the preantibiotic
era human resistome. Here, we characterized the microbiome and resistome of these subjects, and compared them to those of other non-isolated
populations. Samples of the oral cavity (n = 28), forearm skin (n = 28),
and feces (n = 12) were obtained from 34 of the 54 villagers (table S1) at
the time of the first medical expedition to an isolated, previously uncharted
village in the High Orinoco state of Venezuela. The age of the subjects
was between 4 and 50 years, as estimated by Yanomami health workers.

RESULTS
Unprecedented high bacterial and functional diversity in the
microbiome of uncontacted Amerindians
We sequenced the V4 region of the 16S rRNA gene from fecal, oral,
and skin samples and compared these data with those from previous
studies (11, 12). The microbiome of the uncontacted Amerindians exhibited the highest diversity ever reported in any human group. Diversity in feces and skin, but not in the mouth, was significantly higher
in Yanomami than in U.S. subjects (Fig. 1, A, E, and I). Noticeably,
fecal diversity was even higher than in the semitransculturated
Guahibo Amerindians and Malawians [analysis of variance (ANOVA)
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Fig. 1. Microbiota diversity in fecal, oral, and skin sam- I
Yanomami
ples from uncontacted Yanomami in relation to other
US
human groups. (A) Faith’s phylogenetic diversity (PD)
(average ± SD) of fecal samples from Yanomami and
Guahibo Amerindians, Malawians, and U.S. subjects. OTU
tables rarefied at 5000 sequences per sample. Interpopulation differences were significant (P < 0.001, ANOVA with
Tukey’s HSD) for all but Guahibo-Malawi comparison (P =
0.73). (B) PCoA plot based on UniFrac distances calculated
on the OTU table of fecal samples rarefied at 5000 sequences per sample. (C) Top discriminative bacteria among K
L
populations in fecal samples as determined by linear discriminant analysis (LDA) effect size (LEfSe) analysis. (D)
Normalized prevalence/abundance curves for all OTUs
found at 1% abundance or more in fecal samples. (E) Faith’s
phylogenetic diversity (average ± SD) of oral samples from
Yanomami and U.S. subjects. OTU tables rarefied at 1500
sequences per sample. Interpopulation differences were
not significant (P = 0.296, ANOVA with Tukey’s HSD). (F)
PCoA plot based on UniFrac distances calculated on OTU
tables of oral samples rarefied at 1500 sequences per sample. (G) Top discriminative bacteria among populations in oral samples as determined by LEfSe analysis. (H) Normalized prevalence/abundance curves for all
OTUs found at 1% abundance or more in oral samples. (I) Faith’s phylogenetic diversity (average ± SD) of skin samples from Yanomami and U.S. subjects.
OTU tables rarefied at 1500 sequences per sample. Interpopulation differences were significant (P < 0.001, ANOVA with Tukey’s HSD). (J) PCoA plot based
on UniFrac distances calculated on OTU tables of skin samples rarefied at 1500 sequences per sample. (K) Top discriminative bacteria among populations in
skin samples as determined by LEfSe analysis. (L) Normalized prevalence/abundance curves for all OTUs found at 1% abundance or more in skin samples.
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and Tukey’s honest significant difference (HSD) test, P < 0.001; Fig.
1A]. Principal coordinate analysis (PCoA) of UniFrac distances reveals
that bacterial communities from each body site segregate westernized
people from agrarian and hunter-gatherer groups (Fig. 1, B, F, and J,
and fig. S1). Accumulation curves of fecal operational taxonomic units
(OTUs) and phylogenetic species richness (g diversity) confirmed that
the Yanomami harbor significantly higher diversity than other populations (unpaired t test with Bonferroni correction, P < 0.0001; fig. S2A)
and, at the same time, have the lowest microbiome variability (fig.
S2B). Within-population distances in the Yanomami were lower than
those in the semi-accultured Guahibo Amerindians (fig. S2C). Prevalence/
abundance curves further confirm that the Yanomami share a higher
proportion of their fecal microbiota despite their higher diversity (Fig.
1D). These results were consistent with those obtained sequencing the
V2 region of the 16S rRNA gene of the same set of samples extracted,
amplified, and sequenced together with samples from U.S. subjects
(fig. S3).
On the basis of taxa detectable at the obtained sequencing depth,
the Yanomami fecal microbiota was characterized by high Prevotella
and low Bacteroides, contrary to what was observed in U.S. subjects
and similar to that in Guahibo Amerindians, Malawians (fig. S4),
and African hunter-gatherers (13). Analyses of discriminative bacteria
in relation to U.S., Malawian, and Guahibo populations (14) indicated
that Yanomami had higher intestinal Bacteroidales S24-7 (a poorly
characterized family close to the Parabacteroides), Mollicutes and
Verrucomicrobia, members of the families Aeromonadaceae, Oxalobacteraceae, and Methanomassiliicoccaceae, and genera Phascolarctobacterium, Desulfovibrio, Helicobacter, Spirochaeta, and Prevotella (Fig.
1C). Although diet plays a significant role in shaping the microbiome,
factors other than nutrition also influence microbiota composition. For
example, Helicobacter was absent in the feces of U.S. subjects, and intestinal Oxalobacter and Desulfovibrio were markedly increased in the
Yanomami in relation to U.S. subjects (fig. S5).
In contrast to the fecal microbiome, the Yanomami had similar levels of oral bacterial diversity to those found in U.S. subjects (Fig. 1E) despite a distinct composition (Fig. 1F), and higher prevalence of oral taxa
(Fig. 1H). Although both populations were dominated by Streptococcus,
the Yanomami had higher proportions of several oral Prevotella, Fusobacterium, and Gemella, and lower Rothia, Stenotrophomonas, Acinetobacter, or Pseudomonas (Fig. 1G and fig. S4). The Yanomami cutaneous
microbiota had significantly higher diversity (Fig. 1I) and clustered
apart from that of U.S. subjects (Fig. 1J). No single taxon dominated
the Yanomami skin microbiota, in contrast to the low skin bacterial
diversity in U.S. subjects and high relative proportions of Staphylococcus, Corynebacterium, Neisseriaceae, and Propionibacterium (Fig. 1K
and fig. S4). Some bacterial taxa previously reported as environmental,
such as Knoellia or Solibacteraceae (15–17), appeared to be enriched in
the skin microbiota of the Yanomami. As with fecal and oral microbiota, skin bacterial prevalence was also higher in the Yanomami
(Fig. 1L).
Metagenomic predictions using PICRUSt (18) showed distinct microbiome functional profiles for different human populations (Fig. 2,
B, F, and J), with the Yanomami having higher fecal and skin (Fig. 2,
A and I), but not oral (Fig. 2E), functional diversity, higher gene prevalence (Fig. 2, D, H, and L), and lower intragroup variation (fig. S2D).
Pathways involving amino acid metabolism, glycosyltransferases, and
biosynthesis of lipopolysaccharides, terpenoid-quinones, and vitamins
[including riboflavin, previously reported to be increased in nonClemente et al. Sci. Adv. 2015;1:e1500183
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Western populations (11)] were found to be overrepresented in the
Yanomami (Fig. 2C). Their oral mucosa also had significant overrepresentation of pathways of fatty acid biosynthesis, glycosyltransferases,
and methane metabolism (mostly derived from members of the Methylocystaceae) (Fig. 2G). Their skin was enriched in organic acids, amino
acids, vitamins, and methane (originating from Methylobacter, Methylosinus, and Methylocystaceae) pathways (Fig. 2K). Validation of the
predicted bacterial functions by comparing against the sequenced metagenome of the same samples and using a previously reported metagenome from Guahibo Amerindians (11) confirmed the robustness of
our results (see Materials and Methods).
To provide an archive to study human microbial evolution, we isolated 1097 bacterial strains from Yanomami fecal or oral samples. Characterization of 24 Yanomami Escherichia coli strains using multilocus
sequence typing (MLST) based on seven housekeeping genes (19) showed
that they differ substantially from strains circulating in Western societies,
and that none of the isolates belonged to phylogenetic group B2 common
in Western populations (fig. S6).
Presence of AR genes in the microbiome of
uncontacted Amerindians
Phenotypic resistance was tested in 131 Amerindian E. coli strains isolated from 11 fecal specimens. We found that all E. coli isolates were
sensitive to all 23 antibiotics tested. However, functional libraries created from the genomic DNA of 38 of these E. coli isolates, including
the 24 typed strains (table S12), yielded AR genes targeted against
eight antibiotics, including four antibiotics from within the phenotypic
screen (table S3). Overexpression of chromosomally encoded E. coli genes
was likely responsible for most of the resistance (89% have homologs
in E. coli K-12 MG1655; table S4).
For a culture-independent interrogation of the commensal Amerindian resistome, we created shotgun metagenomic libraries from fecal
and oral microbiota of four subjects (table S5) (8, 20) after multiple
displacement amplification (MDA) and screened them against 15 antibiotics (table S6). We identified 28 functional AR genes in the microbiota
of these people naïve to anthropogenic antibiotics (table S4), including
genes resistant to semisynthetic and synthetic antibiotics, to which the
villagers and their surroundings are highly unlikely to have ever been exposed. These genes include an extended-spectrum cblA b-lactamase that
confers resistance to five later-generation antibiotics, including a fourthgeneration cephalosporin and a synthetic monobactam, and penicillinbinding proteins (PBPs) resistant to the third-generation cephalosporin
ceftazidime (Fig. 3A). The six PBPs have 81 to 100% amino acid identity
to PBPs from Neisseria and Kingella, oral commensals in both Western
and Amerindian hosts (21).
Most of the AR genes had close homologs in human microbiota from
industrialized societies. Seventy-nine percent of the AR genes aligned to
the Human Microbiome Project (HMP) assemblies with ≥95% nucleotide identity, and all genes that aligned to HMP (87% of fecal genes) also
aligned to MetaHIT assemblies (Fig. 3B). Only one gene (F3_TE_1), a
ribosomal protection protein (RPP) encoding resistance to tetracycline,
did not align to HMP, MetaHIT, or any protein in National Center for
Biotechnology Information (NCBI) nr (at >70% amino acid identity)
and may be exclusive to this population. Thus, despite different antibiotic exposures, the microbiota from antibiotic-naïve and industrialized
people share a common resistome.
Whole metagenome shotgun sequencing of fecal and oral specimens
from the Amerindian village was performed to quantify the abundance
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Fig. 3. Representative AR genes captured through functional metagenomic selection of Amerindian oral and fecal microbiota. (A) Maximum
likelihood (ML) tree of ceftazidime-resistant PBPs from Amerindian oral microbiota (blue) and their top blastx hits in NCBI nr (black). (B) Identity (%) of
the 28 AR genes to their top hits in HMP and MetaHIT (blastn). Fourteen
aligned to MetaHIT, all isolated from fecal microbiota. (C) Chloramphenicol

acetyltransferase (cat) from O23_CH_21 and homologs in NCBI nt (nucleotide database). Dashed lines indicate 99% identical sequences. Dashes indicate omitted sequence (8487..25716). (D) tetW from F6_TE_1 and
homologs in NCBI nt. Dashed lines indicate 98 to 99% identical sequences.
Sequences are to scale. Yellow, AR gene; red, other resistance genes; green,
mobile genetic elements; purple, bacteriophage genes; blue, other.

of the functionally selected AR genes from the Amerindian microbiota
and from age- and gender-matched individuals from an industrialized
setting (Puerto Rico). Genes from all resistance classes except RPPs
were restricted to their body site of origin, either the fecal or oral microbiota (Fig. 4), perhaps due to tight linkage with a microbial host specific
to that habitat. Antibiotic-resistant PBPs and transporters functionally
selected from Puerto Rican metagenomes were no less abundant in the
Amerindian metagenomes (Wilcoxon rank sum test, Bonferroni correction, P > 0.05), and 72% share ≥95% amino acid identity with commensal Neisseria and Kingella species. However, 14% of the Amerindian
AR genes are syntenic with mobilization elements, including plasmids
and transposases, highlighting the risk for horizontal gene transfer in
response to antibiotic selection (see the Supplementary Materials) (22).
This is likely an underestimation of the mobilization risk, because
many of the AR genes not found to be syntenic with mobilization elements in the Amerindian context are associated with such elements in
industrialized settings and are widespread in commensals and pathogens (Fig. 3, C and D).

DISCUSSION

Clemente et al. Sci. Adv. 2015;1:e1500183
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The characterization of an isolated group of Yanomami hunter-gatherers
here reported represents a unique opportunity to understand a human
microbiome and resistome minimally exposed to modern practices,
which can exert significant antimicrobial effects with lasting consequences in the host (23, 24). The Yanomami here described exhibit unprecedented levels of bacterial diversity. Despite the small population of
this village and the limited sample size of our study, they had significantly higher levels of fecal and skin diversity, both bacterial and
functional, than any other human population reported so far. In contrast
with the large infrequent meals characteristic of Western diets, frequent
meals and food seasonality in the Yanomami would, according to disturbance theory (25, 26), lead to oscillating microbial populations depending on resource availability. The microbiome diversity is more
evenly shared among the Yanomami across all body sites than in other
populations, a phenomenon that could partially be due to cohabitation
(27). However, Guahibo Amerindians living in two different Amazonian
5 of 12
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Fig. 4. Abundance of functionally selected AR genes in Amerindian
fecal and oral metagenomes. The heatmap displays the abundances
in RPKM (reads per 1-kb gene sequence per million reads mapped) of
functionally selected AR genes in the fecal and oral metagenomes of
Amerindians. The AR genes were functionally selected from the oral
and fecal microbiota of the Yanomami individuals and matched Puerto

Rican controls. The shotgun-sequenced metagenomes are from the
Yanomami villagers, including individuals not investigated with functional metagenomic selections. Shotgun-sequenced metagenomes
were clustered by UPGMA (unweighted pair group method with arithmetic
mean) on the AR gene abundance profiles. Fecal and oral microbiota
cluster apart.

villages had less shared fecal taxa and higher within-village distances (fig.
S2C). Together, these results suggest that the isolation and lack of transculturation of the Yanomami can also account for their higher bacterial
diversity and prevalence.
The similarity in oral diversity levels between Yanomami and U.S.
individuals, despite their clear differences in bacterial composition, is
intriguing. Oral hygiene in the Yanomami is limited to occasional
washing of the mouth with water. This factor combined with the ancestral habit of chewing tobacco constantly and from early ages (28)
might explain why the oral microbiota is equally diverse between these
populations.
In the highly diverse skin microbiota of the Yanomami, the presence of environmental bacterial taxa is consistent with their higher
body environmental exposure in relation to westernized people who
wear clothes and spend much time indoors. The extent to which this
environmental exposure contributes to the observed increased skin diversity is currently not known.
Because the Yanomami have remained relatively isolated for more
than 11,000 years since the arrival of their ancestors in the Americas (29),
genomic divergence from Western strains is to be expected. Assuming a
doubling rate of once per hour, an estimated 100 million bacterial generations would have occurred with little gene migration in the Yanomami
microbiome, in relation to the much higher rates in the westernized world.
The bacterial archive gathered from these unique specimens will be of
great value to study evolution of human-associated microbial strains.
Even with no known exposure to pharmacologic-dose antibiotics,
AR genes were present in the microbiome of these uncontacted Amerindians. AR genes against natural antibiotics could have entered the

human microbiota through exchange with antibiotic-producing soil
microbes and neighboring microbes (30, 31) or evolved in a soil-dwelling
ancestor of a human commensal. Resistance to later-generation antibiotics
may represent cross-resistance or a housekeeping gene that provides resistance only in a novel regulatory context (32). Alternatively, AR genes
could have reached the Yanomami via traded objects or a chain of human contact that reached antibiotic-exposed populations. These routes
would require survival of commensal or cosmopolitan microbes in the environment during transfer and/or horizontal gene transfer into the human
microbiota multiple times in the recent past (33). Regardless of their
origin, the AR genes have been maintained in the absence of apparent
antibiotic selection pressure in this very diverse Amerindian microbiome.
The carriage of a pool of mobilizable resistance genes to next-generation
antibiotics in antibiotic-naïve microbiota may help explain the rapidity
with which clinical resistance has arisen to each new antibiotic class
after its introduction (30, 34). Because antibiotics were introduced to the
village after the first medical visit, future studies in this unique setting
would help elucidate their effect on the human microbiome and resistome.
The high shared gene identity with commensal taxa of the source
body site suggests that many of the AR genes are encoded by commensals. Continued carriage of microbes through industrialization may
partially explain a common resistome in uncontacted and industrialized
people. Our discovery of functional AR genes encoded by antibioticsensitive E. coli isolates confirms that culture-dependent screening severely underestimates the potential community resistome (9, 35, 36).
Nevertheless, most of the identified AR genes were part of the E. coli
core genome, in contrast with previous studies of traditional communities
in the Peruvian Amazonas and in Bolivia (9, 37). In these populations,
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which have access to antibiotics and to urban areas, high levels of
acquired resistance to antibiotics and a remarkable diversity of AR
genes and plasmids have been detected in commensal E. coli isolates.
Although AR genes are presumably silenced in Yanomami E. coli isolates of the current study, selection for mutant regulatory regions
could readily occur with the introduction of antibiotic selective pressure, as has been observed clinically (34).
Our work emphasizes the value of deep characterization of microbiomes of people living ancestral life-styles, particularly if practices in
industrialized societies might eradicate potentially beneficial microbes
and their encoded functions. Characterization of the commensal resistome of diverse people will also inform the design and prudent deployment of antibiotics to minimize enrichment for preexisting resistance.
Causation and functional consequences of microbiome changes need to
be understood before functional restoration of the microbiome is possible to attempt to reverse the current global trends in metabolic and
inflammatory diseases.

MATERIALS AND METHODS
Subject and community characterization
The High Orinoco area of Amazonas state in Venezuela is a vast area
(~80,000 km2) of jungle, which is the Venezuelan homeland for about
15,000 Yanomami people living in the country. Most of the villages are
near rivers, but isolated villages still exist in mountainous areas, and they
are described for the first time in the Annual Reports of the Venezuelan
Ministry of Health. In 2008, an unmapped village was sighted by an
army helicopter, and a medical mission landed there in 2009. Ó.N.-A.
was the only author at the site. To protect the identity of the villagers, the
name and coordinates of the village are not provided. The Yanomami
from the uncontacted village were hunters and gatherers, with no agriculture or domestication of livestock. Trade was evidenced by the presence of machetes, cans, or clothing that are commonly exchanged for
arrows with other Yanomami.
The age of the 34 subjects was between 4 and 50 years, as estimated by
Yanomami health workers on the medical team (table S1). The villagers
were observed to eat wild bananas and seasonal fruits, plantain, palm
hearts, and cassava. Hunting consists mostly of birds and small mammals, as well as small crabs, frogs, and small fish from nearby streams,
and occasionally peccary, monkey, and tapir. Water is collected from a
stream about 5-min walking distance from the village. They also knew
the word Medicina from other Yanomami, but the only mission with
a medical dispensary (Mahecoto) is estimated to be at least 2 weeks by
foot through mountainous terrain.
For comparative purposes, we use data from our published studies
of the Guahibo Amerindians and Malawians (11), from villages already in transition toward urban life-styles, with domestication of animals, agricultural practices, some degree of market economy, medical
outposts, and access to towns.
Human specimens
Volar forearm skin, oral mucosa, and fecal samples were collected before the health team vaccinated children and administered antibiotics.
Samples were immediately frozen in liquid nitrogen and remained frozen
until DNA extraction and bacterial culturing were performed.
Samples were cultured on diverse media under aerobic and anaerobic conditions (see below). DNA was also extracted from samples
Clemente et al. Sci. Adv. 2015;1:e1500183
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and bacterial cultures from the Yanomami and from five Puerto Rican
individuals (to examine their resistome), using the PowerSoil DNA
Isolation Kit (MO BIO) following the manufacturer’s recommendations, with the addition of 30-min incubation after the addition of
C6 buffer.
16S rRNA analysis
The V4 region of the 16S rRNA gene was amplified with barcoded primers
and sequenced as previously described (38). a Diversity was estimated
using Faith’s phylogenetic diversity (39) on rarefied tables at 5000 (fecal),
1500 (oral), and 1500 (skin) sequences per sample. b Diversity was measured using unweighted UniFrac (40) on the rarefied tables. g Diversity
(total species diversity within an environment) was estimated using diversity accumulation curves for both mean bacterial genera and phylogenetic species richness as a function of the number of subjects in each
population. LEfSe (14) was used with default parameters on specieslevel OTU tables to determine taxa that best characterize each population; only features with LDA score >2.0 were kept. For presentation
purposes in Fig. 1, features with deeper taxonomic annotation (up to
the genus level) are presented. A complete list of all significant features
is presented in tables S7 to S9. Data from the same set of Yanomami samples generated in combination with a different group of U.S. subjects
(41) using the Illumina Genome Analyzer IIx and the V2 region (27
F-338R) of the 16S rRNA gene were analyzed using the same parameters
as described above, producing consistent results with those obtained
with the V4 region (fig. S3).
Although the main driver of differences in microbiome composition among fecal samples reflected Western versus non-Western lifestyles, PCoA of the non-Western subjects alone also revealed differences
between these populations, with the Yanomami appearing more similar
to the Guahibo than to the Malawians (fig. S7). Because the major differences between Western and non-Western populations were due to
changes within the Bacteroidetes phylum (in particular changes in
the relative abundances of the Bacteroides and Prevotella), we analyzed
non-Bacteroidetes OTUs alone. PCoA analysis of unweighted UniFrac
distances and estimates of bacterial diversity (Faith’s phylogenetic diversity) confirm that taxa outside of the Bacteroidetes phylum are also
responsible for the differences between the Western and non-Western
fecal microbiota (fig. S8).
Normalized prevalence/abundance plots were used to determine
whether the proportion of subjects carrying an OTU is higher in a population regardless of its abundance: For each OTU, a curve was constructed measuring the percentage of a population that carries the OTU
at at least a given abundance (normalized over the total abundance
of the OTU).
Age correlation with bacterial diversity (Faith’s phylogenetic diversity) was examined in all populations and body sites, and only diversity
in Malawian fecal samples had a significant but weak positive correlation with age (fig. S9). This was expected in our village because sampled
subjects were all older than 4 years, when the fecal microbiota already
exhibits an adult-like structure (11).
We expanded the scope of cultures and degree of westernization by
performing a meta-analysis combining our study with data from subjects living in urban (United States, Italy), agrarian (Guahibo, Malawi),
and hunter-gatherer (Hazda, Tanzania) cultures (11, 42) (fig. S1). Data
for Italian and Tanzania subjects were generated using the V4 region
and a 454 GS-FLX Titanium sequencer, which resulted in longer reads
than those obtained with Illumina technologies. Because there is only a
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short overlap [~40 base pairs (bp)] in the sequenced region from
these two technologies, we did not trim sequence length for either
data set, and note that this meta-analysis has some vulnerability
to study effects because of a lack of fully overlapping sequence data.
OTU tables were rarefied at 1000 sequences per sample, and supervised classification was performed using random forests with an out
of bag error model.
Metagenomic prediction and validation
We used PICRUSt 1.0.0 (18) to predict metagenomic content from the
16S rRNA data and STAMP to perform pathway analysis STAMP (43).
Because PICRUSt predictions rely on existing sequenced genomes that
are mainly derived from Western populations, we first compared the sequenced fecal metagenomes of a Western (n = 18) and a non-Western
(n = 10) population (11) against their PICRUSt-predicted metagenomes.
Metagenomic reads were mapped against KEGG Orthology (KO)–
annotated amino acid sequences as previously described (44), and
PICRUSt-predicted metagenomes were estimated using default parameters. To determine the extent to which PICRUSt accuracy is affected by
biases toward Western reference genomes, we also calculated the weighted
nearest sequenced taxon index (NSTI), which measures the average
branch length between OTUs in a sample and a reference genome (higher
scores indicating longer distances and thus a less characterized microbial
environment). The average Spearman correlation was 0.75 (±0.02) in the
Guahibo Amerindians (fig. S2E), close to 0.78 (±0.01) in the U.S. subjects,
and to the 0.80 correlation reported in the original PICRUSt paper (18).
Mean NSTI values are not significantly different (P = 0.158, t test), indicating that the lower correlation between the predicted and sequenced
Guahibo metagenomes is not necessarily due to biases in reference genomes toward those found in Western populations.
In addition, we performed shotgun metagenomic sequencing on
8 fecal and 14 oral samples. Reads passing quality filtering were mapped
as previously described (44). An average of 12.9 ± 8.7% of the reads
were assigned, similar to or higher than values reported elsewhere [for
example, 6.1% in (45)]. Coverage per sample was highly uneven, and we
filtered out low-quality samples as follows. We constructed four subsets of the samples for which both 16S and metagenomic data were
available: all samples (“all”), samples with ≥10,000 mapped metagenomic
sequences (“10 K”), ≥20,000 mapped sequences (“20 K”), and ≥100,000
mapped sequences (“100 K”). For each of these subsets, we performed
100 rarefactions at increasing sequencing depth levels (all: 100/500/
1000/5000; 10 K, 20 K, 100 K: 1000/5000/10,000) and calculated BrayCurtis similarity and PCoA. For each sample subset and each of the
200 (100 for 16S and 100 for metagenomic) PCoA plots thus obtained,
we performed Procrustes analysis (46). We found that the 10 K subset
achieved the best fit at any rarefaction level (fig. S10), as shown by the
lower average M2 (goodness of fit between 16S and metagenomic data,
with lower values indicating better fit), and samples with less than
10,000 reads mapped (F23, F36, F49, F50, and O18) were excluded
from further analyses.
Pearson correlation between the sequenced and PICRUSt metagenome was high except for oral samples O4 and O13 (fig. S11A).
In addition, we performed Procrustes analysis using Bray-Curtis
distances on 100 rarefied tables for sequenced and PICRUSt-predicted
metagenomes. One hundred Monte Carlo simulations were additionally performed on each of the PICRUST versus shotgun comparisons to estimate a P value. All permutations were significant (P <
0.01) and M2 values were generally low (0.27 ± 0.01), further indiClemente et al. Sci. Adv. 2015;1:e1500183
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cating that there is a good fit between shotgun and PICRUSt data
(fig. S11, B and C).
We investigated whether, despite the low and uneven coverage obtained, bacterial contigs could be assembled from the Yanomami data.
We used velvet (47) to assemble the metagenomic reads into contigs
(k = 31 to 91). The obtained assembly was fragmentary and composed
mostly of short contigs (fig. S12A). Bacterial taxonomy was assigned
to each contig by aligning them to IMG genomes using nucmer (48)
(minimum identity >90% over at least 80% of the query length). Contigs were clustered using CONCOCT (49), and cluster quality was assessed on the basis of the taxonomic assignments for contigs within a
cluster using scripts provided in CONCOCT. Although most clusters
could not be unequivocally assigned to a single species, we could confirm some of the taxa identified in the Yanomami samples through
16S sequencing (table S10). Cluster quality was measured for all k-mer
lengths and at three minimum contig lengths (100, 200, and 500 bp) using
NMI (normalized mutual information), F1 score, Rand index, and adjusted Rand index (fig. S12B). A subset of k-mer values were selected for
each contig length upon inspection of the quality metrics, and a PCoA
plot was generated for clusters obtained with those k-mer sizes and contig lengths (fig. S12C). Overall, these results indicate that we might
lack coverage to faithfully reconstruct bacterial genomes using current
data. The functional uniqueness of the microbiota in these uncontacted Amerindians may be a result of their isolation for more than
11,000 years since the arrival of their ancestors in the Americas, and genomic divergence from bacterial strains found in Western populations
is therefore to be expected. Assuming a doubling rate of once per hour
to once per day, an estimated 4 to 100 million bacterial generations would
have occurred with little gene migration in the Yanomami microbiome,
in contrast to the higher rates in the westernized world.
Cultures and E. coli analyses
We isolated 1097 bacterial strains from frozen fecal or oral samples
from the uncontacted Amerindians to provide an archive to study
human microbial evolution. Specimens were cultured in seven different media [blood, chocolate, McConkey, Columbia, trypticase
soy agar (TSA), CDC anaerobic blood agar (CDC), and Brucella
Laked Blood Agar with Kanamycin and Vancomycin (LKV)] under
aerobic and anaerobic (jars, bags, and anaerobic chamber) conditions at 37°C.
After 16S rRNA sequencing of 329 isolates (table S11), we characterized 24 E. coli isolates from fecal samples by MLST of seven housekeeping
genes (19). MLST analysis was performed using the scheme at the University College of Cork (UCC) E. coli MLST Web site (http://mlst.ucc.ie),
which is based on the housekeeping genes adk, fumC, gyrB, icd, mdh,
purA, and recA (19). Polymerase chain reaction (PCR) was performed
according to protocol (http://mlst.ucc.ie/mlst/dbs/Ecoli/documents/
primersColi_html). All PCR products were purified using the QIAquick
PCR Purification Kit (Qiagen) and sequenced in both directions. Nucleotide sequences were quality-controlled, edited, aligned, and trimmed
with the SeqMan (DNASTAR Inc.). All nucleotides within the consensus sequence template were supported by at least two sequence chromatograms. A unique allele number was assigned to each distinct sequence
within a locus, and a distinct sequence type (ST) number was assigned
to each unique combination of alleles. Allele and ST assignments were
made and deposited at the publicly accessible E. coli UCC MLST database (http://mlst.ucc.ie/mlst/dbs/Ecoli) (19). Genetic relationships of
Amerindian E. coli isolates were assessed by comparing allelic profiles
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of Amerindian isolates with existing profiles present in the MLST
database. The BURST clustering algorithm was used to define clonal
complexes (CCs) of related isolates derived from a common ancestor,
the patterns of descent linking them together, and the ancestral genotype (50, 51). Isolates were grouped into CCs if they differed at no more
than one locus from at least one other member of the group (51). Founder
genotypes of CCs were defined as the ST of the CC with the highest number of neighboring single-locus ST variants. All samples were confirmed to be E. coli by sequencing the 16S rRNA gene. Isolates belonged
to 19 STs (table S12), of which 12 were novel, indicating that uncontacted people harbor unique strains. eBURST comparison of 19 STs
found in Amerindians with that of the 3544 STs that represent the full
global diversity of this species revealed that our isolates represented a
broad diversity. This analysis also revealed that most of our isolates were
distributed in six CCs, with three STs appearing as singletons (ST-3316,
ST-164, and ST-3415) (table S12). These singletons were assigned to
CC-10 (differing in less than one locus from at least one other member
of the group) when less stringent conditions were used (that is, STs
sharing five or more alleles). Two CCs in particular had more than five
Amerindian isolates (CC-10 and CC-58, respectively). These data suggest ongoing strain or genetic transfer among the E. coli populations
of the individuals in our study, probably facilitated by the fact that all
lived in the same village with limited external contact.
The ECOR collection of 72 reference strains (52), which represent
the breadth of genetic diversity within the species E. coli, was included
for phylogenetic analysis. In-frame–concatenated sequences were aligned
using MUSCLE (53), and the ML tree was reconstructed with the HKY85
model of DNA evolution (100 bootstrap replicates) using PhyML (54). In
PhyML, the transition/transversion ratio, proportion of invariant sites,
and the g shape parameter were estimated, and subtree-pruning and regrafting and nearest-neighbor interchange tree topology search methods
were used. Escherichia fergusonii was used as an outgroup to root the
E. coli phylogeny. Gene sequences from all seven MLST loci were also
analyzed using ClonalFrame version 1.2 (55), a Bayesian method of constructing evolutionary histories that takes both mutation and recombination into account. Five independent runs were performed, each
consisting of 100,000 iterations, including a 50,000 burn-in. Analyses from
five independent runs were concatenated to construct a 50% majorityrule consensus tree. MEGA5 (56) was used to draw the consensus
phylogenetic tree.
AR phenotypes in E. coli from Amerindians
Of the 329 fecal bacterial isolates (table S11), 131 were E. coli. Of these,
all were tested for susceptibility to 23 antibiotics.
MDA of metagenomic DNA
We performed MDA on fecal and oral metagenomic DNA from
Amerindian subjects 3, 5, 6, and 23 and the five Puerto Rican subjects
with the illustra GenomiPhi V2 DNA Amplification Kit (GE Healthcare
Life Sciences). The recommended protocol was followed with a 2-hour
incubation. We pooled three to six reactions per sample to reduce MDA
template amplification bias.
Creation of metagenomic libraries
Small-insert metagenomic libraries were constructed from the MDAamplified metagenomic DNA in the vector pZE21 as previously described
(table S5) (20, 31, 57). The DNA fragments cloned into pZE21 contain
several bacterial genes and are situated downstream of the constitutively
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active pLTetO-1 promoter, enabling expression and phenotypic selection
of the shotgun-cloned fragments.
Creation of E. coli isolate genomic libraries
The E. coli isolate genomic libraries were created from 38 isolates from
the 11 individuals who provided fecal samples. The number of isolates
per individual ranged from 1 to 7. Genomic DNA (500 ng each) from
38 E. coli isolates was combined into two pools, each containing DNA
from 19 isolates. Genomic DNA was not amplified with MDA. Smallinsert libraries (libraries A and B) were created from the pooled genomic DNA using the procedure above (table S2).
Functional selection of libraries for AR
Metagenomic and genomic libraries were plated on Mueller-Hinton
agar supplemented with kanamycin (50 mg/ml) (the selection marker
in the pZE21 vector) and another antibiotic (table S6). Puerto Rican and
E. coli isolate libraries were not selected against nitrofurantoin. Antibiotic
concentrations were clinically relevant concentrations recommended by
the Clinical and Laboratory Standards Institute or the minimum inhibitory concentration of the library host MegaX transformed with selfligated pZE21. In all cases, antibiotic concentrations inhibited MegaX
transformed with self-ligated pZE21. Surviving colonies were pooled.
In some cases, resistant colonies were confirmed by replating on solid
media (F6 cefepime and O23 tetracycline selections) or by inoculating
into liquid media (F6 cefepime, 238 penicillin, F3, F6, F23, T1001 tetracycline, O3 chloramphenicol, 238, 337, T1001 piperacillin-tazobactam,
O23, T1001, library B ceftazidime, and library A and B aztreonam selections) containing the selective antibiotic at the same concentration. Reselected clones were used as the template for sequencing.
Sequencing and assembly of resistance-conferring inserts
Resistance-conferring inserts were isolated from pooled surviving colonies via PCR with vector-specific primers, barcoded, and sequenced in
parallel with the Illumina HiSeq 2000 (2 × 101-bp reads). Reads were assembled into contigs, and open reading frames were identified with
PARFuMS and then annotated with Resfams (31, 58). The sequences
of the F6 cefepime, O23 tetracycline, and E. coli library A ceftazidimeresistant inserts were determined by paired-end Sanger sequencing performed at the Protein and Nucleic Acid Chemistry Laboratory (PNACL)
at Washington University School of Medicine. For F6_AZ_9, F6_CT_1,
O3_CZ_2_1, O3_CZ_2_2, O3_TE_1, O23_TE_1, F23_TE_1, F6_CH_4,
O23_CH_19, and F23_CH_11, Sanger sequencing was performed at
PNACL or at Genewiz with specific primers to confirm portions of the
sequence, and the Sanger sequence was used for all analyses.
Computational filtering of assembled contigs from
metagenomic libraries
Nonspecific amplification is frequently observed for MDA with commercial MDA reagents, particularly with small amounts of starting template
(59). A total of 171 ng of DNA was amplified from three no-template
control (NTC) reactions performed in parallel with the Amerindian sample amplifications, ~15× less output DNA per reaction than for the
fecal and oral samples (57 ± 25 ng versus 854 ± 67 ng). There was no
detectable amplification in the NTCs for the Puerto Rico sample amplifications (<0.25 ng each). We shotgun-sequenced 84 ng of the Amerindian NTC product without antibiotic selection and assembled the reads
with the same procedure as the sample reads. To ensure the authenticity of the genes identified in the metagenomic functional selections,
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we excluded any sample contig from analysis that aligned to an NTC
contig with at least 99% nucleotide identity over at least 200 bp (113
Amerindian and 4 Puerto Rican contigs). Additionally, we excluded
any sample contig whose best hit in NCBI nt (16 August 2013) was
a vector or mouse/human DNA, provided that the alignment was at
least 200 bp long and had 99% sequence identity (four and two Amerindian contigs, respectively, and no Puerto Rican contigs). E. coli isolate libraries were not filtered because they did not undergo MDA. We
did not consider any contigs under 500 bp.
AR gene identification
From the contigs that passed computational filtering, AR genes were
identified on the basis of Resfams annotations specific to that antibiotic class, similarity to known resistance genes (for transporters), or
subcloning and functional confirmation. The genes F23_TE_1:69-1403,
O23_TE_1:1-1845, O23_CH_19:550-804, and F23_CH_11:1298-1636
were PCR-amplified from their respective antibiotic selections with primers encompassing the entire gene. They were ligated into pZE21 at an
optimal distance from the RBS (ribosome binding site) and transformed
into E. coli DH10B. The resistance phenotype was confirmed by plating
on the selective antibiotic at the same concentration used in the initial
selection and amplification of the fragment from surviving colonies with
specific primers.
Alignment to NCBI
AR genes were compared to NCBI nr (non-redundant protein
database) (downloaded 15 September 2014; including uncultured/
environmental sample sequences) via blastx. The top hit was the hit
with the lowest e value; any hits with the same e value and score were
also considered top hits. Alignments 200 bp or shorter were excluded
from analysis. Global %ID (table S4) was calculated from estwise (Wise2
package) sequence alignments. To compare the context of AR genes in
contigs isolated from Amerindian metagenomes and in industrialized settings, genes and the surrounding contigs were compared to NCBI nt
(15 August 2013).
Tree building for Amerindian PBPs
For each gene, the top blastx hit in NCBI nr and any hit with amino acid
identity ≥99% and coverage ≥90% of the gene was downloaded from
NCBI. Proteins were clustered with cd-hit at 99.5% identity (60), and
the representative sequence for each cluster was used for tree building.
Functionally isolated AR genes were translated with EMBOSS Transeq
(61, 62). The phylogenetic tree was created with the Phylogeny.fr pipeline (63). Proteins were aligned with MUSCLE (Full Mode) (53), and
PhyML3.0 (54, 64) was used to create the phylogenetic tree (default parameters, default substitution model, SH-like approximate likelihood ratio
test for branch support), which was visualized with Geneious version 7.0
(Biomatters).
Alignment of functionally selected AR genes to the
HMP and MetaHIT
AR genes were compared to the HMP (65) and MetaHIT (66) shotgun
assemblies (HMP: 749 assemblies, http://www.hmpdacc.org/HMASM/;
MetaHIT: 124 assemblies, NCBI/European Bioinformatics Institute accession ERA000116, http://www.bork.embl.de/~arumugam/Qin_et_al_2010/)
via blastn. The reported sequence identity for each gene is that of the
top alignment (lowest e value) in that database. Alignments 200 bp or
shorter were excluded from analysis.
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Alignment to E. coli MG1655
All AR genes isolated from the E. coli genomic libraries were compared to
E. coli str. K-12 substr. MG1655 (RefSeq: NC_000913.3) on 19 September 2014 to determine the gene identity. All genes with MG1655
alignments (39 of 44 genes) aligned with ≥96% nucleotide identity.
Filtering of human sequences from shotgun reads
Human sequences were filtered from the forward-only trimmed shotgun reads by mapping to the human reference genome (GRCh38) with
DeconSeq (67). Filtered reads were uploaded to the NCBI Sequence
Read Archive (SRA) (SRP049631) and mapped to resistance genes.
Comparison of shotgun reads to functionally selected
resistance genes
All functionally selected AR genes from the Amerindian and Puerto
Rican oral and fecal metagenomic libraries and the Amerindian E. coli
isolate genomic DNA libraries were clustered with cd-hit-est at 100%
nucleotide identity over the length of the smaller gene (60). Forwardonly trimmed and filtered shotgun reads from Amerindian fecal and
oral microbiota were mapped to the clustered AR genes with bowtie2
(end-to-end alignment, one alignment per read) (68). Alignments
were filtered to those with an alignment score ≥−0.3278 × the length
of the read (~95% ID). Gene abundance in the metagenome was
calculated as the number of reads mapping to the gene by the length
of the gene in kilobases by millions of reads mapped. A Bray-Curtis
dissimilarity matrix was calculated in R (package vegan, function vegdist) (69) from the gene × sample abundance table. Samples were
clustered on the dissimilarity matrix with UPGMA (function hclust).
Heatmaps of gene abundance were generated with R packages NMF
and RColorBrewer (70, 71). Statistical differences in abundance between categories were calculated with Wilcoxon rank sum tests and
corrected for multiple hypotheses with a Bonferroni correction.

SUPPLEMENTARY MATERIALS
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